NCT00047645View on ClinicalTrials.gov

A Study of the Safety and Efficacy Interferon-Gamma 1b in Patients With Idiopathic Pulmonary Fibrosis (IPF)

PHASE3CompletedINTERVENTIONAL
Enrollment

330

Participants

Timeline

Start Date

April 30, 2000

Study Completion Date

December 31, 2002

Conditions
Idiopathic Pulmonary Fibrosis
Interventions
DRUG

Interferon-gamma 1b

200 mcg, SQ, 3x per week

Trial Locations (1)

98195

University of Washington Medical Center, Seattle

Sponsors

Lead Sponsor

InterMune
All Listed Sponsors
lead

InterMune

INDUSTRY

NCT00047645 - A Study of the Safety and Efficacy Interferon-Gamma 1b in Patients With Idiopathic Pulmonary Fibrosis (IPF) | Biotech Hunter | Biotech Hunter